ChemicalBook >> CAS DataBase List >>Isoprinosine

Isoprinosine

CAS No.
36703-88-5
Chemical Name:
Isoprinosine
Synonyms
methisoprinol;Metisoprinol;25mm;13mm;np113;0.8um;aviral;)(1:3);0.22um;0.45um
CBNumber:
CB2437987
Molecular Formula:
C24H34N6O9
Molecular Weight:
550.57
MDL Number:
MFCD05662374
MOL File:
36703-88-5.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-07-27 17:00:41

Isoprinosine Properties

Melting point 140-142°C
storage temp. Inert atmosphere,Room Temperature
solubility DMSO (Slightly, Heated), Methanol (Slightly, Heated, Sonicated), Water (Slightly)
form Solid
color White to Off-White
Merck 14,4976
InChIKey PBJNZCQJMWVIRT-JHVGCDEENA-N
SMILES O[C@@H]1[C@@H]([C@@H](CO)O[C@H]1N1C=NC2C(N=CNC1=2)=O)O.C(N(C)C)C(O)C.N(C1C=CC(C(=O)O)=CC=1)C(=O)C |&1:1,2,3,7,r|
FDA UNII W1SO0V223F
ATC code J05AX05

Pharmacokinetic data

Excreted unchanged in urine Majority (as metabolites)
Biological half-life 50 minutes

SAFETY

Risk and Safety Statements

Symbol(GHS)  Exclamation Mark (GHS07)
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338
HS Code  2934.99.9001
Toxicity LD50 in mice and rats (mg/kg): >4000 orally and i.p. (Gordon)

Isoprinosine price More Price(55)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
TCI Chemical I1037 Inosine Pranobex >98.0%(HPLC)(T) 36703-88-5 100mg $21 2026-04-30 Buy
TCI Chemical I1037 Inosine Pranobex >98.0%(HPLC)(T) 36703-88-5 1g $64 2026-04-30 Buy
Cayman Chemical 16492 Isoprinosine ≥98% 36703-88-5 10mg $49 2026-04-30 Buy
Cayman Chemical 16492 Isoprinosine ≥98% 36703-88-5 50mg $143 2026-04-30 Buy
Cayman Chemical 16492 Isoprinosine ≥98% 36703-88-5 100mg $259 2026-04-30 Buy
Product number Packaging Price Buy
I1037 100mg $21 Buy
I1037 1g $64 Buy
16492 10mg $49 Buy
16492 50mg $143 Buy
16492 100mg $259 Buy

Isoprinosine Chemical Properties,Uses,Production

Description

ISOPRINOSINE (also known as inosine pranobex) an antiviral drug combing of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is mainly used for treating the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy1,2. In UK, it is also indicated for mucocutaneous infections due to herpes simplex virus (type 1 and type 2) and for treatment of genital warts as adjunctive therapy to podophyllin or carbon dioxide laser1. It also has certain efficacy in the treatment of AIDS and some other acquired immunodeficiency such as aged patients, cancer patients, severely burned patients, ill patients, and surgery patients3. Preclinical studies have demonstrated that isoprinosine can inhibit the growth of both DNA and RNA viruses as well as potentiate cell-mediated immune response both in vitro and in vivo4,5.

Sources

  1. https://en.wikipedia.org/wiki/Inosine_pranobex
  2. Waldman, R. H., and R. Ganguly. "Therapeutic efficacy of inosiplex (Isoprinosine) in rhinovirus infection. " Annals of the New York Academy of Sciences 284.1(1977):153–160.
  3. https://www.ncbi.nlm.nih.gov/pubmed/2446760
  4. https://www.ncbi.nlm.nih.gov/pubmed/83189
  5. https://www.drugbank.ca/drugs/DB13156

Chemical Properties

White powder, odorless and tasteless. Soluble in water.

Uses

Isoprinosine is a new combination of active substances for the treatment of chronic systemic diseases such as cancer. Isoprinosine is an immunomodulator; antiviral. The ratio is between 1: 2 : 2 to 1 : 3 : 3

Biological Activity

isoprinosine is a complex of acetaminobenzoic acid, dimethylaminoisopropanol, and inosine in a 3:3:1 ratio with immunomodulatory effects.immunotherapy is the treatment of disease by inducing, enhancing, or suppressing an immune response. immunomodulatory regimens usually have fewer side effects than existing drugs, such as less potential for creating resistance when treating microbial disease.

Mechanism of action

Isoprinosine is thought to act through a receptor for an inosine-like compound on T cell precursors. In vivo it appears to induce the production of more mature T cells and there is some evidence that it can increase the CD4:CD8 ratio in a variety of conditions. In addition, Isoprinosine enhances B-lymphocyte activity, possibly through effects on helper T cells. It also increases macrophage phagocytosis, releases cytokines that induce macrophage proliferation, including immune interferon and interleukin-1 (IL-1) and IL-2, and potentiates T-cell mitogens.

Clinical Use

Treatment of mucocutaneous herpes simplex, genital warts, subacute sclerosing panencephalitis

in vitro

previous study found that increasing concentrations of isoprinosine (50-400 μg/ml) could produce progressively growing inhibitory effect on hhv-1 replication. the combination of 1000 iu/ml ifn-α and isoprinosine could result in enhanced anti-hhv activity [1].

in vivo

previous study demonstrated the positive effect of isoprinosine treatment on persistent infection of balb/c mice with murine gammaherpesvirus 68. increased number of leukocytes, increased percentage of neutrophils, elevated levels of virus-neutralizing antibodies, reduced number of atypical lymphocytes and reduced virus titers were detected in the examined organs after a 14-day treatment. the positive effect of isoprinosine therapy vanished after 120-150 days [2].

Metabolism

Hepatically metabolised. The major excretion product of the inosine moiety is uric acid, while the p-acetamidobenzoic acid and N,N-dimethylamino- 2-propanol components are excreted in the urine as glucuronidated and oxidised products, respectively, as well as being excreted unchanged

References

[1] majewska a, lasek w, janyst m, mynarczyk g. in vitro infibition of hhv-1 replication by inosine pranobex and interferon-α. acta pol pharm. 2016 may-jun;73(3):637-44.
[2] janíková o, anicová l, briestenská k, mistríková j. the effect of isoprinosine treatment on persistent infection of balb/c mice infected with murine gammaherpesvirus 68. acta virol. 2017;61(1):32-38. doi: 10.4149/av_2017_01_32.
[3] beran j, alapová e, pajdel m; isoprinosine study (ewo iso-2014/1) team. inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a phase 4, randomised, placebo-controlled, double-blind study. bmc infect dis. 2016 nov 7;16(1):648.

Isoprinosine Preparation Products And Raw materials

Global( 414)Suppliers
Supplier Tel Email Country ProdList Advantage
Watson Biotechnology Co.,Ltd 027-59207879 1972026995 18140587686 sales@3600chem.com China 4200 55
Hubei Yihao Biotechnology Co., Ltd. 18995688786 156716255@qq.com China 260 58
Wuhan Juchengyuan Biotechnology Co., Ltd 400-027-6007 18062142210 804180422@qq.com China 145 58
Shandong Jihao Biotechnology Co., Ltd. 0531-69958659 15668363232 8598038@qq.com China 46 58
Hubei Baoling Chemical Technology Co. , Ltd. 13129969326 1241628333@qq.com China 1010 58
J & K SCIENTIFIC LTD. 18210857532 18210857532 jkinfo@jkchemical.com China 96815 76
TCI (Shanghai) Development Co., Ltd. 021-67121386 Sales-CN@TCIchemicals.com China 24512 81
Pure Chemistry Scientific Inc. 001-857-928-2050 or 1-888-588-9418 sales@chemreagents.com United States 10174 62
Adamas Reagent, Ltd. 400-6009262 15618770481 yhx@titansci.com China 14098 59
Wuhan Wei Shunda Technology Development Co., Ltd. 86-027-88774375 mwmwhot@163.com China 233 65

Related articles

View Lastest Price from Isoprinosine manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Isoprinosine pictures 2026-09-10 Isoprinosine
36703-88-5
25KG 95.0%-105.0% 500kg/month WUHAN FORTUNA CHEMICAL CO., LTD
Inosine Pranobex pictures 2026-09-10 Inosine Pranobex
36703-88-5
1kg 99%min 500KG WUHAN FORTUNA CHEMICAL CO., LTD
Isoprinosine pictures 2026-09-10 Isoprinosine
36703-88-5
0.99 RongNa Biotechnology Co.,Ltd
  • Isoprinosine pictures
  • Isoprinosine
    36703-88-5
  • $0.00
  • 95.0%-105.0%
  • WUHAN FORTUNA CHEMICAL CO., LTD

Isoprinosine Spectrum

ISOPRINOSINE )(1:3) aviral delimmun imunovir inosine,compd.with1-(dimethylamino)-2-propanol4-(acetylamino)benzoate(salt inosinepranobex inosiplex isoprinosin isoviral Isopranosine MethisoprinoluM (Inosine pranobex) inosine, compound with (2-hydroxypropyl)dimethylammonium p-acetamidobenzoate (1:3) Isoprinosine(Methisoprinol) np113 ntp10381 viruxan Nitroglycerin Solution Impurity II:Glycerol 1,3-dinitrate solution 9-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purin-6-one Groprinosin Immunovir nosine pranobex Isoprinosine (Inosine Pranobex) 4-Acetamidobenzoic acid,9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3H-purin-6(9H)-one,1-(Dimethylamino)propan-2-ol (3:1:3) Indosine Pranobeox ISOPRINOSINE USP/EP/BP Inosin, Verbindung mit (2-Hydroxypropyl)dimethylammonium-p-acetamidobenzoat (1:3) Indosine Pranobeox,Inosiplex,Methisoprinol, Isopropyl inosine 0.22um 0.45um 0.8um Inosine pranobex (Imunovir Isoprinosina Inosine, compd. with 1-(dimethylamino)-2-propanol4-(acetylamino)benzoate (salt) (1:3)OTHER CA INDEX NAMES:2-Propanol, 1-(dimethylamino)-, 4-(acetylamino)benzoate (salt),compd. with inosine (3:1)Benzoic acid, 4-(acetylamino)-, compd. with1-(dimethylamino)-2-propanol and inosine (3:3:1) Inosine pranobex, 10 mM in DMSO Isoprinosine (Nosine Pranobex) Inosine pranobexInosine pranobex 0,20μm MinisartNYGF 25mm 13mm 4-ethylacylaminobenzenemacetic acid,9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3H-purine-6(9H)-one,1-(dimethylamino)propyl-2-ol(3:1:3) 5'-O-DMT-2'-MOE-N4-Ac-cytidine methisoprinol Metisoprinol 36703-88-5 36703-88-3 C10H12N4O53C9H9NO33C5H13NO C52H78N10O17 36703-88-5